These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 12601548

  • 21. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T, Gimeno JR, Bahl A, Steffensen U, Steffensen M, Osman E, Thaman R, Mogensen J, Elliott PM, Doi Y, McKenna WJ.
    J Am Coll Cardiol; 2007 Jun 26; 49(25):2419-26. PubMed ID: 17599605
    [Abstract] [Full Text] [Related]

  • 22. [Genetic changes and clinical management in familial hypertrophic cardiomyopathy].
    Domal-Kwiatkowska D, Smolik S, Mazurek U, Moric E, Polońska J, Nowalany-Kozielska E, Glanowska G, Wodniecki J, Szarek J, Wilczewski P, Kozakiewicz K, Tendera M, Wilczok T.
    Wiad Lek; 2000 Jun 26; 53(1-2):4-21. PubMed ID: 10806915
    [Abstract] [Full Text] [Related]

  • 23. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
    Taylor MR, Carniel E, Mestroni L.
    Expert Rev Mol Diagn; 2004 Jan 26; 4(1):99-113. PubMed ID: 14711353
    [Abstract] [Full Text] [Related]

  • 24. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ, McGarry K, Seidman JG, Seidman CE.
    J Clin Invest; 2002 Feb 26; 109(3):357-62. PubMed ID: 11827995
    [Abstract] [Full Text] [Related]

  • 25. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC, Palmer BM, Stauffer BL, Leinwand LA, Moore RL.
    Circ Res; 2004 Feb 06; 94(2):201-7. PubMed ID: 14670849
    [Abstract] [Full Text] [Related]

  • 26. One third of Danish hypertrophic cardiomyopathy patients with MYH7 mutations have mutations [corrected] in MYH7 rod region.
    Hougs L, Havndrup O, Bundgaard H, Køber L, Vuust J, Larsen LA, Christiansen M, Andersen PS.
    Eur J Hum Genet; 2005 Feb 06; 13(2):161-5. PubMed ID: 15483641
    [Abstract] [Full Text] [Related]

  • 27. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.
    Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L, Bogoyevitch MA, Seidman CE, Seidman JG, Semsarian C.
    Circulation; 2008 Apr 08; 117(14):1820-31. PubMed ID: 18362229
    [Abstract] [Full Text] [Related]

  • 28. Human homozygous R403W mutant cardiac myosin presents disproportionate enhancement of mechanical and enzymatic properties.
    Keller DI, Coirault C, Rau T, Cheav T, Weyand M, Amann K, Lecarpentier Y, Richard P, Eschenhagen T, Carrier L.
    J Mol Cell Cardiol; 2004 Mar 08; 36(3):355-62. PubMed ID: 15010274
    [Abstract] [Full Text] [Related]

  • 29. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP, van Dijk SJ, Stienen GJ, van Rossum AC, van der Velden J, Germans T.
    Eur J Clin Invest; 2011 May 08; 41(5):568-78. PubMed ID: 21158848
    [Abstract] [Full Text] [Related]

  • 30. Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure.
    Tsoutsman T, Bagnall RD, Semsarian C.
    Clin Exp Pharmacol Physiol; 2008 Nov 08; 35(11):1349-57. PubMed ID: 18761664
    [Abstract] [Full Text] [Related]

  • 31. Sarcomere mutations in cardiogenesis and ventricular noncompaction.
    McNally E, Dellefave L.
    Trends Cardiovasc Med; 2009 Jan 08; 19(1):17-21. PubMed ID: 19467449
    [Abstract] [Full Text] [Related]

  • 32. [Hypertrophic cardiomyopathy].
    Bundgaard H, Havndrup O, Høst U, Kelbaek H.
    Ugeskr Laeger; 1998 Sep 14; 160(38):5478-83. PubMed ID: 9763919
    [Abstract] [Full Text] [Related]

  • 33. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH, Zheng DD, Dong NZ, Yang XJ, Song JP, Jiang TB, Cheng XJ, Li HX, Zhou BY, Zhao CM, Jiang WP.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1785-9. PubMed ID: 17097032
    [Abstract] [Full Text] [Related]

  • 34. Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy.
    Kärkkäinen S, Heliö T, Jääskeläinen P, Miettinen R, Tuomainen P, Ylitalo K, Kaartinen M, Reissell E, Toivonen L, Nieminen MS, Kuusisto J, Laakso M, Peuhkurinen K.
    Eur J Heart Fail; 2004 Dec 05; 6(7):861-8. PubMed ID: 15556047
    [Abstract] [Full Text] [Related]

  • 35. Low-density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy.
    Waldmüller S, Freund P, Mauch S, Toder R, Vosberg HP.
    Hum Mutat; 2002 May 05; 19(5):560-9. PubMed ID: 11968089
    [Abstract] [Full Text] [Related]

  • 36. Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy.
    Hengstenberg C, Carrier L, Schwartz K, Maisch B.
    Herz; 1994 Apr 05; 19(2):84-90. PubMed ID: 8194836
    [Abstract] [Full Text] [Related]

  • 37. Cardiac and skeletal muscle expression of mutant β-myosin heavy chains, degree of functional impairment and phenotypic heterogeneity in hypertrophic cardiomyopathy.
    Di Domenico M, Casadonte R, Ricci P, Santini M, Frati G, Rizzo A, Carratelli CR, Lamberti M, Parrotta E, Quaresima B, Faniello CM, Costanzo F, Cuda G.
    J Cell Physiol; 2012 Oct 05; 227(10):3471-6. PubMed ID: 22213221
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy.
    Redwood CS, Moolman-Smook JC, Watkins H.
    Cardiovasc Res; 1999 Oct 05; 44(1):20-36. PubMed ID: 10615387
    [Abstract] [Full Text] [Related]

  • 40. Genes, calcium and modifying factors in hypertrophic cardiomyopathy.
    Tsoutsman T, Lam L, Semsarian C.
    Clin Exp Pharmacol Physiol; 2006 Oct 05; 33(1-2):139-45. PubMed ID: 16445713
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.